Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE)
-
Giuseppe Lippi
, Janne Cadamuro
, Elisa Danese
, Julien Favresse
, Tomris Ozben
and Jecko Thachil
To the Editor,
According to the World Health Organization (WHO), the European region is in a “polycrisis” and “permacrisis” that goes far beyond pandemic, climate change, and war [1]. The ongoing coronavirus disease 2019 (COVID-19) pandemic, with hundreds of millions of confirmed cases and over 3 million recorded deaths in Europe so far, is another crisis that has put health at the top of the scientific agenda [2]. Then, there is the current monkeypox emergency that is causing additional international concern [3]. And, finally, there is the devastating war in Ukraine, which unfortunately shows no signs of de-escalation and is exacerbated by horrific attacks on healthcare facilities and providers [4]. Other potentially devastating scenarios include climatic emergencies (tornadoes, thunderstorms, hail), earthquakes and tsunamis, fires, floods, chemical/biological/radiological emergencies, plane crashes, terrorism and bioterrorism, civil unrest, and so on. Specifically, with respect to infectious diseases, the response capabilities of clinical laboratories are necessary to ensure the timeliness, completeness, and accuracy of case reporting during outbreaks and enhance feedback and transparency.
The past has taught us that laboratory medicine is largely unprepared for most of these challenges [5], [6], [7]. For this reason, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has decided to establish a Task Force called “Preparation of Labs for Emergencies”, specifically designed to improve preparedness and put into practice appropriate solutions for laboratory diagnostics in areas impacted by various anthropogenic and non-anthropogenic emergencies. Specifically, the terms of reference encompass actions such as (i) surveying the state of the art in EFLM countries to understand the state of laboratory preparedness for emergencies across Europe and potentially identify (or establish) a benchmark, (ii) identifying priority areas (i.e., types of emergencies) to become specific targets for laboratory medicine in emergencies, and (iii) providing guidance on appropriate strategies to prepare laboratory medicine facilities for emergencies. As a very first step, therefore, the Task Force designed a special survey to gather a wide range of information on the preparedness of European laboratories for emergencies, the results of which are reported and discussed here.
The survey, which includes a series of questions about the nature, organization, and preparedness for emergencies, was created using Google forms (the layout is still available here: https://docs.google.com/forms/d/e/1FAIpQLScqjqn0w13MrbuXMMg3D66RcdRdwx9hxy3GxoPNEoN2opGMlA/viewform). The survey was officially mailed to over 12,000 potential EFLM contacts with an official newsletter to collect responses between May 8 and June 8, 2023. Responses were downloaded into an Excel spreadsheet and analyzed graphically.
During the one-month period, 235 responses were collected, 200 of which were from European countries and represented the basis for the following analyses. Most responses came from Italy (20.0 %), followed by Serbia (9.0 %), Turkey (6.5 %), Spain (5 %), Croatia, Romania, Lithuania (all 4.0 %), while each other single country contributed <3 %. Most respondents were from public laboratories (78 %) and worked in general laboratories (74.5 %) that also perform urgent/stat tests (88.5 %). Most of these laboratories performed <1 million tests per year (42.0 %), followed by laboratories performing between 1 and 4 million tests per year (32.0 %), while 15.5 % of all respondents worked in large laboratories performing more than 8 million tests per year.
Responses regarding the availability of a recovery plan at the national, hospital, or laboratory level are shown in Figure 1A. After subtracting “I don’t know” responses, the majority of respondents indicated that a recovery plan exists for selected emergencies across all the three healthcare settings (47–49 %), while approximately 20 % of respondents indicated that no recovery plan exists.

Responses to the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE).
We then ranked the responses to the question “Rank the threats that are more likely to disrupt the function of your local laboratory based on organization and geographical location” adding the “moderately likely” and “likely” options. It was found that epidemics/pandemics and heat waves topped the list with over 50 % “likely” responses, followed by “transportation and other incidents,” “drought,” “floods,” “earthquakes,” and “heavy snow/ice storms” (between 40 and 50 % of “likely” responses). Terrorism/bioterrorism, firestorms/wildfires, explosions, radiation/chemical/biological poisoning, war/civil disorders and thunderstorms/hurricanes were cited as less likely causes of disruption to laboratory operations in Europe (20–30 % of likely responses), while volcanic eruptions were rated as only about 5 % likely to disrupt laboratory operations (Figure 1B).
For the question “Rank the system failures that scare you more for the functioning of your lab”, we also grouped those who responded “Medium concern” and “High concern”. This showed that the most worrisome problems were “Laboratory Information System (LIS) failure”, “Shortage of test reagents/supplies” and “Blackout and/or local interruption of energy supply” (≥80 % of worrisome responses), followed by “Hospital Information System (HIS) failure”, “Personnel shortage (due to lab inaccessibility, isolation, etc.)” and “Interruption of water supply” (between 70 and 80 % of worrisome responses), whist “Interruption of air conditioning system” was a concern for 65 % of all respondents (Figure 1C).
Responses to the question “What would you do during prolonged (i.e., >3–6 h) LIS/HIS failure” are summarized in Figure 1D. Most laboratories (over 60 %) responded that they would only test “stat” or “emergency” samples, while a significant number of respondents (i.e., about 40 %) also indicated that they would continue to perform all tests on all samples manually. The percentage of respondents who would “Stop receiving routine samples”, who would “Stop receiving all samples” and who would “Not process any sample” were 20, 2 and 5 %, respectively.
In response to the question “Do you have backup energy power supply in your laboratory/hospital (more than one can be selected)?” only 5 % of respondents indicated that they do not have any form of emergency power supply, the majority answered that they have a dedicated UPS (uninterrupted power supply) for some equipment (80 %), but almost half of respondents indicated that they have a generator for the entire laboratory (48 %) (Figure 1E).
Finally, only 6.4 % of respondents indicated that they were not interested in receiving advice from the EFLM on this topic. Of those who were interested instead, the majority made no distinction as to the form of guidance, while the majority of those who indicated a preference mentioned recommendations most frequently (49 %), followed by official guidelines (35 %) and general indications (16 %).
Although obviously not representative of all European countries, the collected data provides an overview of the current situation with respect to laboratory readiness for emergencies. Thus, the results of this first survey of the EFLM Task Force-Preparation of Labs for Emergencies will provide an essential foundation for the development of official recommendations for managing disruptive emergencies in European medical laboratories.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: The authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: The data can be obtained on reasonable request from the corresponding author.
References
1. Bendell, J. Replacing sustainable development: potential frameworks for international cooperation in an era of increasing crises and disasters. Sustainability 2022;14:8185. https://doi.org/10.3390/su14138185.Search in Google Scholar
2. Busse, R, Muscat, NA, de la Mata, I, Figueras, J. Lessons learned from the COVID-19 pandemic. Health Pol 2022;126:347. https://doi.org/10.1016/j.healthpol.2022.04.003.Search in Google Scholar PubMed PubMed Central
3. Rizk, JG, Lippi, G, Henry, BM, Forthal, DN, Rizk, Y. Prevention and treatment of monkeypox. Drugs 2022;82:957–63. https://doi.org/10.1007/s40265-022-01742-y.Search in Google Scholar PubMed PubMed Central
4. Almoshantaf, MB, Swed, S, Sakkour, R, Shoib, S. War and health crisis: humanitarian catastrophe in Ukraine. Int J Surg 2023. https://doi.org/10.1097/JS9.0000000000000051 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central
5. Lippi, G, Favaloro, EJ, Plebani, M. Laboratory medicine and natural disasters: are we ready for the challenge? Clin Chem Lab Med 2010;48:573–5. https://doi.org/10.1515/cclm.2010.148.Search in Google Scholar
6. Mattiuzzi, C, Lippi, G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020;8:48. https://doi.org/10.21037/atm.2020.02.06.Search in Google Scholar PubMed PubMed Central
7. Lippi, G, Plebani, M. COVID-19: the global health emergency is over for the WHO, but not yet for laboratory medicine. J Lab Precis Med 2023. https://doi.org/10.21037/jlpm-23-25.Search in Google Scholar
© 2023 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Adherence to recommendations and clinical practice guidelines: not an easy task
- Reviews
- Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis
- Review on adherence of the literature to official recommendations on albuminuria harmonization and standardization
- Opinion Paper
- The total testing process harmonization: the case study of SARS-CoV-2 serological tests
- IFCC Paper
- Quality standards and internal quality control practices in medical laboratories: an IFCC global survey of member societies
- Guidelines and Recommendations
- Toolkit for emerging technologies in laboratory medicine
- Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies
- Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: Methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies
- Genetics and Molecular Diagnostics
- The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy
- General Clinical Chemistry and Laboratory Medicine
- The stability of C-peptide and insulin in plasma and serum samples under different storage conditions
- Self-sampling of blood using a topper and pediatric tubes; a prospective feasibility study for PSA analysis using 120 prostate cancer patients
- Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease
- Uncertainty in measurement and the renal tubular reabsorption of phosphate
- Urine transfer devices may impact urinary particle results: a pre-analytical study
- Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
- Early changes in S100B maternal blood levels can predict fetal intrauterine growth restriction
- Reference Values and Biological Variations
- Interpreting two TSH results from the same patient
- Cancer Diagnostics
- Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer
- Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy
- Infectious Diseases
- Performance evaluation of SARS-CoV-2 antigen detection in the post-pandemic era: multi-laboratory assessment
- Serum sPD-L1 levels are elevated in patients with viral diseases, bacterial sepsis or in patients with impaired renal function compared to healthy blood donors
- Letters to the Editor
- Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE)
- Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood
- Bilirubin color interference on prothrombin time and activated partial thromboplastin time tests assessed in patients with liver disease
- Laboratory response to paradigm change in hemophilia treatment
- MALDI-ISD mass spectrometry analysis as a simple and reliable tool to detect post-translational modifications of hemoglobin variants: the case of Hb Raleigh
- Method validation for a greener approach to the quantification of 25-hydroxy vitamin D3 in patient serum using supported liquid extraction and liquid chromatography-tandem mass spectrometry
- Interest of minigene splicing reporter assay in familial hypobetalipoproteinemia genetic diagnosis: the example of the missense mutation APOB c.1468C>T
- Laboratory medicine unveiling an unusual cause of D-lactic acidosis as the trigger of decompensation of a rare inborn error of metabolism
Articles in the same Issue
- Frontmatter
- Editorial
- Adherence to recommendations and clinical practice guidelines: not an easy task
- Reviews
- Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis
- Review on adherence of the literature to official recommendations on albuminuria harmonization and standardization
- Opinion Paper
- The total testing process harmonization: the case study of SARS-CoV-2 serological tests
- IFCC Paper
- Quality standards and internal quality control practices in medical laboratories: an IFCC global survey of member societies
- Guidelines and Recommendations
- Toolkit for emerging technologies in laboratory medicine
- Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies
- Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: Methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies
- Genetics and Molecular Diagnostics
- The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy
- General Clinical Chemistry and Laboratory Medicine
- The stability of C-peptide and insulin in plasma and serum samples under different storage conditions
- Self-sampling of blood using a topper and pediatric tubes; a prospective feasibility study for PSA analysis using 120 prostate cancer patients
- Albumin determined by bromocresol green leads to erroneous results in routine evaluation of patients with chronic kidney disease
- Uncertainty in measurement and the renal tubular reabsorption of phosphate
- Urine transfer devices may impact urinary particle results: a pre-analytical study
- Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
- Early changes in S100B maternal blood levels can predict fetal intrauterine growth restriction
- Reference Values and Biological Variations
- Interpreting two TSH results from the same patient
- Cancer Diagnostics
- Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer
- Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy
- Infectious Diseases
- Performance evaluation of SARS-CoV-2 antigen detection in the post-pandemic era: multi-laboratory assessment
- Serum sPD-L1 levels are elevated in patients with viral diseases, bacterial sepsis or in patients with impaired renal function compared to healthy blood donors
- Letters to the Editor
- Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE)
- Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood
- Bilirubin color interference on prothrombin time and activated partial thromboplastin time tests assessed in patients with liver disease
- Laboratory response to paradigm change in hemophilia treatment
- MALDI-ISD mass spectrometry analysis as a simple and reliable tool to detect post-translational modifications of hemoglobin variants: the case of Hb Raleigh
- Method validation for a greener approach to the quantification of 25-hydroxy vitamin D3 in patient serum using supported liquid extraction and liquid chromatography-tandem mass spectrometry
- Interest of minigene splicing reporter assay in familial hypobetalipoproteinemia genetic diagnosis: the example of the missense mutation APOB c.1468C>T
- Laboratory medicine unveiling an unusual cause of D-lactic acidosis as the trigger of decompensation of a rare inborn error of metabolism